TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Albany Molecular Research Inc (NASDAQ: AMRI) Investor Securities Class Action Lawsuit 11/12/2014

  • If you purchased shares of Albany Molecular Research Inc (NASDAQ: AMRI), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

February 9, 2017 - A stipulation of settlement was filed by the parties. July 26, 2016 - The court denied defendants' motion to dismiss. November 20, 2015 - A motion to dismiss the amended complaint was filed. March 31, 2015 - An amended complaint was filed. November 12, 2014 - An investor in shares of Albany Molecular Research Inc (NASDAQ: AMRI) filed a lawsuit in the U.S. Distr...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: